Cyproteron Mylan 50 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

cyproteron mylan 50 mg tablett

mylan ab - cyproteronacetat - tablett - 50 mg - cyproteronacetat 50 mg aktiv substans; laktosmonohydrat hjälpämne - cyproteron

Abiraterone Mylan Europeiska unionen - svenska - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abirateronacetat - prostatiska neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Accord Europeiska unionen - svenska - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Krka Europeiska unionen - svenska - EMA (European Medicines Agency)

abiraterone krka

krka, d.d., novo mesto - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Sapropterin Aurobindo 100 mg Löslig tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sapropterin aurobindo 100 mg löslig tablett

aurobindo pharma (malta) limited - sapropterindihydroklorid - löslig tablett - 100 mg - sapropterindihydroklorid 100 mg aktiv substans; mannitol hjälpämne

Cyproteronacetat Ebb 50 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

cyproteronacetat ebb 50 mg tablett

ebb medical ab - cyproteronacetat - tablett - 50 mg - cyproteronacetat 50 mg aktiv substans; laktosmonohydrat hjälpämne

Abirateron Aristo 500 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

abirateron aristo 500 mg filmdragerad tablett

aristo pharma gmbh - abirateronacetat - filmdragerad tablett - 500 mg - abirateronacetat 500 mg aktiv substans; laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne

Sapropterin Teva 100 mg Löslig tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

sapropterin teva 100 mg löslig tablett

teva gmbh - sapropterindihydroklorid - löslig tablett - 100 mg - sapropterindihydroklorid 100 mg aktiv substans; mannitol hjälpämne

Sapropterin Dipharma Europeiska unionen - svenska - EMA (European Medicines Agency)

sapropterin dipharma

dipharma arzneimittel gmbh - sapropterin dihydrochloride - phenylketonurias - andra matsmältningsorgan och ämnesomsättning produkter, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

Abiraterone medac 250 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

abiraterone medac 250 mg tablett

medac gesellschaft für klinische spezialpräparate mbh - abirateronacetat - tablett - 250 mg - abirateronacetat 250 mg aktiv substans; laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne